PL2634171T3 - 23-ynowa pochodna witaminy D3 - Google Patents

23-ynowa pochodna witaminy D3

Info

Publication number
PL2634171T3
PL2634171T3 PL11836202T PL11836202T PL2634171T3 PL 2634171 T3 PL2634171 T3 PL 2634171T3 PL 11836202 T PL11836202 T PL 11836202T PL 11836202 T PL11836202 T PL 11836202T PL 2634171 T3 PL2634171 T3 PL 2634171T3
Authority
PL
Poland
Prior art keywords
yne
vitamin
derivative
Prior art date
Application number
PL11836202T
Other languages
English (en)
Inventor
Hiroshi Saito
Masato Komiyama
Eiji Ochiai
Kenichiro Takagi
Takayuki Chida
Mariko Fujita
Keiichiro Imaizumi
Toshiyuki Kaneko
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of PL2634171T3 publication Critical patent/PL2634171T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B61/00—Other general methods
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL11836202T 2010-10-25 2011-10-24 23-ynowa pochodna witaminy D3 PL2634171T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010238524 2010-10-25
PCT/JP2011/074414 WO2012057068A1 (ja) 2010-10-25 2011-10-24 ２３－イン－ビタミンｄ３誘導体
EP11836202.9A EP2634171B8 (en) 2010-10-25 2011-10-24 23-yne-vitamin d3 derivative

Publications (1)

Publication Number Publication Date
PL2634171T3 true PL2634171T3 (pl) 2015-12-31

Family

ID=45993776

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11836202T PL2634171T3 (pl) 2010-10-25 2011-10-24 23-ynowa pochodna witaminy D3

Country Status (21)

Country Link
US (2) US9006220B2 (pl)
EP (1) EP2634171B8 (pl)
JP (1) JP5738307B2 (pl)
KR (1) KR101853518B1 (pl)
CN (2) CN104829510B (pl)
AR (1) AR083541A1 (pl)
AU (1) AU2011321624B2 (pl)
BR (1) BR112013009647A2 (pl)
CA (1) CA2815501C (pl)
DK (1) DK2634171T3 (pl)
ES (1) ES2541719T3 (pl)
HK (2) HK1184133A1 (pl)
HU (1) HUE025554T2 (pl)
IL (1) IL225630A0 (pl)
MX (1) MX347126B (pl)
PL (1) PL2634171T3 (pl)
PT (1) PT2634171E (pl)
RU (1) RU2558362C2 (pl)
SG (1) SG189427A1 (pl)
TW (1) TWI503120B (pl)
WO (1) WO2012057068A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201406380A (zh) * 2012-04-24 2014-02-16 Teijin Pharma Ltd 次發性副甲狀腺機能亢進症治療劑
JP2020143008A (ja) * 2019-03-05 2020-09-10 達也 楠堂 新規褐色脂肪細胞分化誘導剤
CN114681467B (zh) * 2022-03-30 2024-03-12 南通华山药业有限公司 一种阿法骨化醇杂环酯类衍生物在制备抗肿瘤药物中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
AU666563B2 (en) * 1992-08-07 1996-02-15 Wisconsin Alumni Research Foundation Preparation of 19-nor-vitamin D compounds
SG70010A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Fluorinated vitamin d3 analogs
SG70009A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Vitamin d3 analogs
GB9611603D0 (en) * 1996-06-04 1996-08-07 Leo Pharm Prod Ltd Chemical compounds
KR100593238B1 (ko) 1997-06-25 2006-06-26 데이진 가부시키가이샤 비타민 ｄ3 유도체 및 이로부터 제조된 염증성 호흡기 질환 치료제
US6359152B2 (en) * 1997-07-21 2002-03-19 Wisconsin Alumni Research Foundation 18-substituted-19-nor-vitamin D compounds
US5939406A (en) 1997-07-21 1999-08-17 Wisconsin Alumni Research Foundation 18-substituted-19-nor-vitamin D compounds
US6538145B2 (en) * 1998-02-24 2003-03-25 Chugai Seiyaku Kabushiki Kaisha 24-hydroxy vitamin D derivatives
WO1999043645A1 (fr) 1998-02-24 1999-09-02 Chugai Seiyaku Kabushiki Kaisha Derives de 24-hydroxyvitamine d
EP1070704A4 (en) 1998-04-10 2001-11-07 Chugai Pharmaceutical Co Ltd VITAMIN D DERIVATIVES SUBSTITUTED IN THE 2 BETA POSITION
CN1398254A (zh) 2000-02-28 2003-02-19 中外制药株式会社 具有2α位取代基的维生素D衍生物
WO2006036813A2 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
JP2009013154A (ja) 2006-09-29 2009-01-22 Teijin Pharma Ltd ２−置換−１４−エピ−プレビタミンｄ３誘導体

Also Published As

Publication number Publication date
WO2012057068A1 (ja) 2012-05-03
TWI503120B (zh) 2015-10-11
CA2815501C (en) 2018-10-16
HUE025554T2 (en) 2016-02-29
EP2634171A4 (en) 2013-11-13
US9006220B2 (en) 2015-04-14
AR083541A1 (es) 2013-03-06
EP2634171B1 (en) 2015-07-01
CN104829510A (zh) 2015-08-12
HK1211281A1 (zh) 2016-05-20
MX2013004389A (es) 2013-05-22
EP2634171A1 (en) 2013-09-04
ES2541719T3 (es) 2015-07-24
JP5738307B2 (ja) 2015-06-24
RU2558362C2 (ru) 2015-08-10
US9079843B2 (en) 2015-07-14
JPWO2012057068A1 (ja) 2014-05-12
KR101853518B1 (ko) 2018-04-30
PT2634171E (pt) 2015-09-16
KR20140001874A (ko) 2014-01-07
TW201223531A (en) 2012-06-16
US20130210781A1 (en) 2013-08-15
CN103180293B (zh) 2015-06-17
BR112013009647A2 (pt) 2016-07-12
AU2011321624B2 (en) 2015-03-26
IL225630A0 (en) 2013-06-27
CA2815501A1 (en) 2012-05-03
MX347126B (es) 2017-04-17
AU2011321624A1 (en) 2013-05-09
EP2634171B8 (en) 2016-01-13
HK1184133A1 (en) 2014-01-17
CN103180293A (zh) 2013-06-26
RU2013124033A (ru) 2014-12-10
US20150148552A1 (en) 2015-05-28
SG189427A1 (en) 2013-05-31
CN104829510B (zh) 2016-05-04
AU2011321624A8 (en) 2013-09-12
DK2634171T3 (en) 2015-07-13

Similar Documents

Publication Publication Date Title
AP3607A (en) Substituted imidazopyridazines
HK1171452A1 (en) Substituted pyrrolidine-2-carboxamides -2-
HK1182594A1 (en) N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives n3--n1--5-
ZA201300032B (en) Tetrahydrocarboline derivative
PL2590974T3 (pl) Pochodne tetrahydropirydo-pirymidyny
HK1188782A1 (en) Substituted sodium-1h-pyrazole-5-olate 1h--5-
HK1185082A1 (en) Acylbenzene derivative
EP2599775A4 (en) ETHINYLPYRAZOLDERIVAT
GB2490849B (en) Di-aspirin derivatives
HK1174625A1 (en) Pyrrazolopyridine derivatives
HK1211281A1 (zh) -炔-維生素 衍生物
HU1000243D0 (en) 8-hidroxy-quinoline derivatives
ZA201303887B (en) 2-carboxamide-4-piperazinyl-benzofuran derivative